Increasing the Quality and Efficiency of Clinical Trials (R18)
ArchivedFood and Drug Administration
Description
The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is announcing its intent to accept and consider a single source application for the award of a grant to the Duke University’s Duke Translational Medicine Institute (DTMI) to support increasing the quality and efficiency of clinical trials.
Who can apply
- Others
Contact
Lisa Ko <br/>Grants Management Specialist
lisa.ko@fda.hhs.gov
- PostedMay 27, 2014
- ClosesJun 30, 2014
- Award ceiling$7,500,000
- Program funding$7,500,000
- Expected awards1
- CFDA93.103
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro